{"disease":{"id":"oropharyngeal-neoplasms","name":"oropharyngeal neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04266093","title":"Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03239834","title":"Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making","phase":"","overall_status":"COMPLETED","enrollment_count":893,"lead_sponsor_name":"Vigilant Biosciences, Inc.","has_results":false},{"nct_id":"NCT06642324","title":"Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas","phase":"","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","has_results":false},{"nct_id":"NCT06356272","title":"Oropharynx (OPX) Biomarker Trial","phase":"","overall_status":"RECRUITING","enrollment_count":440,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06167291","title":"Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04260126","title":"Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"PDS Biotechnology Corp.","has_results":false},{"nct_id":"NCT05412628","title":"Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT01687413","title":"Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":42,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT00721799","title":"F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University of Iowa","has_results":true},{"nct_id":"NCT02792322","title":"Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03074110","title":"Isocapnic Hyperventilation - an Alternative Method","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT04015336","title":"E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04044950","title":"A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}